Skip to main content
Pollywatch
Federal supplier · FY 20132026

SINAPSE

$2.2 million

Lifetime federal contract value awarded across 8 contract notices.

ABN
40130269868
Country
AUSTRALIA
State
VIC

Awarded by financial year

  • 2014-15$0
  • 2015-16$0
  • 2016-17$0
  • 2017-18$0
  • 2018-19$371,800
  • 2019-20$0
  • 2020-21$0
  • 2021-22$0
  • 2022-23$0
  • 2023-24$0
  • 2024-25$0
  • 2025-26$213,400

Top agencies awarded to this supplier

  • Department of Veterans' Affairs$1,660,401
  • Department of Defence$475,200
  • Department of Infrastructure, Transport, Regional Development, Communications, Sport and the Arts$110,000

Contracts (8)

Click any CN ID to verify the contract notice on AusTender.

  1. $110,000
    Department of Infrastructure, Transport, Regional Development, Communications, Sport and the Arts
    Advisory Services
    Published 16 Mar 2026
  2. $103,400
    Department of Defence
    Organisational Design
    Published 22 Dec 2025
  3. $371,800
    Department of Defence
    Technical Change Review
    Published 22 Jan 2019
  4. $24,530
    Department of Veterans' Affairs
    Procure tools to enhance the VVCS reporting capability for VERA.
    Published 15 June 2014
  5. $26,077
    Department of Veterans' Affairs
    Develop customised reporting requirements for VVCS/VERA.
    Published 16 Mar 2014
  6. $30,500
    Department of Veterans' Affairs
    VMIS/VERA Change Request - Develop Improved Backup Procedures for VERA.
    Published 8 Dec 2013
  7. $55,000
    Department of Veterans' Affairs
    Procurement of an application for the VMIS replacement for PCEHR Project - Travel Expenses
    Published 5 May 2013
  8. $1,524,294
    Department of Veterans' Affairs
    Procurement of an application for the VMIS replacement for PCEHR Project.
    Published 14 Apr 2013

Sources

  • Department of Finance · 2013 onward · CC-BY 3.0 AU

    Each row above can be verified by clicking the CN ID to view the source notice on AusTender. Methodology at /methodology/#contracts.

Refreshed 23 May 2026 · Caveats